top of page

CHO-K1/Human PKR2 Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0192A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


PKR2 (Prokineticin receptor 2) is a G protein-coupled receptor encoded by the PROKR2 gene, belonging to the prokineticin receptor family. It is primarily distributed in the central nervous system (e.g., olfactory bulb, hypothalamic suprachiasmatic nucleus, hippocampus, amygdala) and peripheral tissues such as the testis and thyroid gland. Its core function involves binding to the ligand prokineticin 2 (PROK2) and activating multiple G proteins (Gq/11, Gi, and Gs), leading to intracellular calcium mobilization and MAPK pathway activation. It plays crucial roles in circadian rhythm regulation, GnRH neuron migration and reproductive axis development, olfactory bulb neurogenesis, pain perception, and energy metabolism. Mutations in this receptor gene are closely associated with idiopathic hypogonadotropic hypogonadism (with or without anosmia) and Kallmann syndrome.

 

Screeningbio’s CHO-K1/Human PKR2 cell line overexpress PROKR2 receptor and is designed to detect increases in intracellular IP-1 levels in response to agonist stimulation of the receptor. Cisbio HTRF IP-1 kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

PROKR2

Accession Number

NM_144773 (Hs)

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data

CHO-K1/Human PKR2 Agonist Assay. CHO-K1/Human PKR2 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.
CHO-K1/Human PKR2 Agonist Assay. CHO-K1/Human PKR2 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.


Target Background


PKR2 (Prokineticin receptor 2) is a G protein-coupled receptor encoded by the PROKR2 gene, belonging to the prokineticin receptor family. It is primarily distributed in the central nervous system (e.g., olfactory bulb, hypothalamic suprachiasmatic nucleus, hippocampus, amygdala) and peripheral tissues such as the testis and thyroid gland. Its core function involves binding to the ligand prokineticin 2 (PROK2) and activating multiple G proteins (Gq/11, Gi, and Gs), leading to intracellular calcium mobilization and MAPK pathway activation.


It plays crucial roles in circadian rhythm regulation, GnRH neuron migration and reproductive axis development, olfactory bulb neurogenesis, pain perception, and energy metabolism. Mutations in this receptor gene are closely associated with idiopathic hypogonadotropic hypogonadism (with or without anosmia) and Kallmann syndrome.

Product Documentation



Screeningbio

For research use only. All rights reserved. Not for use in diagnostic procedures, human or veterinary treatment, food, cosmetics, or household applications. ScreeningBio provides laboratory research products and R&D services to qualified research organizations. We do not sell pharmaceuticals, dietary supplements, or products intended for human consumption.

6181 Cornerstone Ct, Suite 102, San Diego, CA 92121, USA

Quick Links

Connect

  • Facebook
  • Twitter
  • LinkedIn

CHINA: 上海格宁生物

info@screeningbio.com

4th Floor, Building 24, No.1188 Lianhang Road Minhang District, Shanghai, China

bottom of page